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We describe a 1-step reverse-transcription loop-medi-
ated isothermal ampliﬁ  cation assay for detection of highly 
pathogenic avian inﬂ   uenza A (H5N1) viruses. The assay 
was tested by using a panel of highly pathogenic H5N1 
subtypes isolated over the past 10 years and clinical speci-
mens. The assay produced negative results for all non-
H5N1 subtypes.
H
ighly pathogenic avian inﬂ  uenza A (H5N1) virus has 
had a signiﬁ  cant global effect on the poultry indus-
try, human healthcare, and many other sectors (1). Several 
molecular tests have been developed for the rapid detec-
tion of inﬂ  uenza (H5) virus subtypes (2), but they often 
require sophisticated equipment (e.g., PCR machine) and 
are difﬁ  cult for researchers and clinicians to perform in 
resource-limited settings. Loop-mediated isothermal am-
pliﬁ  cation (LAMP) provides a molecular testing option 
for this scenario (3). The LAMP mechanism has been de-
scribed (3,4). Using this approach, nucleic acids are am-
pliﬁ  ed under isothermal conditions (e.g., in a water bath) 
with high speciﬁ  city, efﬁ  ciency, and speed (3). The assay 
is highly speciﬁ  c due to recognition of target DNA by 6 
independent sequences. An attractive feature of LAMP 
is its ability to generate large amounts of white magne-
sium pyrophosphate precipitate in positive reactions (4). 
Examples of positive and negative reactions are shown in 
online Appendix Figure 1 (available from www.cdc.gov/
EID/content/13/6/899-appG1.htm). LAMP enables easy 
visual identiﬁ  cation of positive reactions (4,5) and avoids 
additional cost and labor for postampliﬁ  cation analysis. 
This closed-tube method can also minimize the problem of 
carryover contamination in less controlled environments.
The Study
We aimed to develop a reverse transcription (RT) 
LAMP assay that could detect a variety of highly pathogen-
ic inﬂ  uenza (H5N1) viruses. For primer design, we used 
highly pathogenic inﬂ   uenza (H5N1) sequences publicly 
available from the Inﬂ  uenza Sequence Database (www.
ﬂ  u.lanl.gov/index.html) in August 2006. We used hemag-
glutinin (HA) from an inﬂ  uenza (H5N1) prototype vac-
cine strain (A/Vietnam/1203/2004, GenBank accession no. 
AY651334) as the reference for this study. The sequences 
included highly pathogenic inﬂ  uenza (H5N1) viruses iden-
tiﬁ  ed in the past 2 years. In addition, sequences from all 
the other HA subtypes (e.g., 1,127 for H1 and 1,472 for 
H3) in the above database were used for the analysis. Be-
cause highly pathogenic inﬂ  uenza (H5N1) gene sequences 
are genetically diverse, all studied H5 sequences (n = 711) 
were aligned, and a highly conserved region at the 5′ end of 
HA2 encoding sequence (corresponding to nt 1,065–1,298 
of the reference sequence) was selected as the target (online 
Appendix Figure 2A, available from www.cdc.gov/EID/
content/13/6/899-appG2.htm, and online Appendix Figure 
3, available from www.cdc.gov/EID/content/13/6/899-app 
G3.htm). Of all the downloaded highly pathogenic inﬂ  u-
enza (H5N1) sequences, 115 did not contain the target site 
and were excluded from analysis. The GenBank acces-
sion numbers for the highly pathogenic inﬂ  uenza (H5N1) 
sequences used for the primer design are listed in the on-
line Appendix Table (available from www.cdc.gov/EID/
content/13/6/899-appT.htm).
Previous demonstration that degenerate primers could 
be used in LAMP assays (6) led us to use the same ap-
proach for designing a set of degenerate primers for the 
targeted region (online Appendix Figure 2B). Our HA 
sequence analysis also showed that HA sequences from 
inﬂ  uenza (H5N2) viruses of North American lineage and 
other viruses with other HA subtypes contain extensive 
mismatches to the primers used in the LAMP assay (online 
Appendix Figure 2A, B). In the initial phase of the study, 
we used the reference strain (A/Vietnam/1203/2004) to de-
termine the sensitivity of the assay. Puriﬁ  ed RNA from a 
viral supernatant with a known titer was serially diluted and 
subjected to the LAMP assay. As shown in the Figure, pan-
el A, the detection limit of the assay was found to be 2×10–3 
plaque-forming units (pfu) per reaction. The sensitivity of 
this assay was also compared with that of an optimized RT-
PCR assay recommended by the World Health Organiza-
tion (7). As shown in the Figure, panel A, the detection 
limit of the RT-PCR assay was identical to that from the 
LAMP assay. We also spiked various amounts of inﬂ  uenza 
(H5) viruses into non-H5 nasopharyngeal aspirate samples 
and tested the puriﬁ  ed RNA from these clinical specimens 
by the LAMP and RT-PCR assays. The results from these 
assays were identical (data not shown). These ﬁ  ndings are 
in accordance with previous ﬁ  ndings that the sensitivity of 
LAMP assays is comparable to that of conventional PCR 
methods (5,6,8). In addition, all positive reactions were vi-
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sually examined for the presence of white precipitate at the 
end of the reaction incubation. As expected, all results cor-
related exactly with those deduced by the real-time turbid-
ity meter (data not shown).
We also tested the feasibility of using this assay to 
detect inﬂ  uenza (H5) viruses in clinical specimens from 
a patient with inﬂ  uenza (H5). RNA from 2 different post-
mortem lung tissue samples from a patient infected with 
inﬂ  uenza A/HK/212/03 was subjected to the LAMP assay. 
As shown in the Figure, panel B, both RNA samples had 
positive results for the inﬂ  uenza (H5) viruses.
To evaluate the speciﬁ  city of the LAMP assay for 
inﬂ  uenza (H5) viruses, a comparative study including all 
16 HA subtypes and a variety of H5N1 strains was per-
formed (Table). All 14 H5N1 strains isolated from differ-
ent geographic regions during the past 10 years were posi-
tive, whereas none of the non-H5 samples were positive 
(Table). All the reactions were visually examined, and the 
results corresponded with those generated from the real-time 
turbidity meter. Inﬂ  uenza A/chicken/Wajo/BBVM/2005, 
A/duck/Vietnam/568/2005, and A/bar-headed goose/Qin-
ghai/5/2005 are clade 2 inﬂ  uenza (H5N1) viruses that have 
recently emerged from different geographic regions (9), 
and these 3 viruses are phylogenetically distinct (10,11). 
Our results demonstrate that this assay is applicable to a 
wide variety of highly pathogenic inﬂ  uenza (H5N1) virus-
es. In addition, other virus reassortants with the HA of this 
lineage are expected to be positive in the assay.
We previously demonstrated that heat-treated blood 
samples could be directly tested by a LAMP assay speciﬁ  c 
for DNA of a bloodborne pathogen (5). These modiﬁ  ca-
tions could avoid the need for nucleic acid puriﬁ  cation, 
thereby reducing the cost and turnaround time for molecu-
lar diagnosis. We tested the feasibility of detecting the H5 
sequence from viral cultures without RNA extraction. In 
a Biosafety Level 3 facility, 50 μL of viral culture of the 
prototype virus was heat inactivated (99°C for 10 min), the 
heat-treated sample was serially diluted with standard viral 
culture medium, and 2 μL of serially diluted samples was 
added to the LAMP assay. As shown in the Figure, panel C, 
Figure. Detection of inﬂ   uenza (H5) virus by loop-mediated isothermal ampliﬁ   cation (LAMP). A) Serially diluted RNA from 
A/Vietnam/1203/2004 was tested by the reverse transcription (RT)–LAMP (upper panel) and RT-PCR (lower panel) assays. The viral titers 
used in these reactions are indicated. Viral RNA was extracted by using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA) 
according to the manufacturer’s instructions. For a typical 25-μL reaction, 2 μL of sample was mixed with 2× in-house reaction buffer 
(40 mmol/L Tris-HCl, pH 8.8; 20 mmol/L KCl; 16 mmol/L MgSO4; 20 mmol/L [NH4]2SO4; 0.2% Tween 20 [v/v]; 1.6 mol/L betaine; 2.8 mmol/L 
each dNTP), 50 U Bst DNA polymerase (New England Biolabs, Ipswitch, MA, USA), 8 U avian myeloblastosis virus reverse transcriptase 
(Invitrogen, Gaithersburg, MD, USA), 40 pmol/L primers FIP and BIP, 20 pmol/L primers LPF and LPR, and 5 pmol/L primers F3 and B3. 
Reaction mixtures were incubated at 60ºC for 120 min, and the turbidity of these reactions was examined by use of a turbidity meter (LA-
200, Treamecs; Kyoto, Japan) in real time. The turbidities of these reactions 5–20 min after incubation were taken as the baseline. The 
threshold value for a positive reaction was set to be 10× above the standard deviation of the baseline. For the H5-speciﬁ  c RT-PCR assay, 
primers H5-1 (5′-GCCATTCCACAACATACACCC-3′) and H5-3 (5′-CTCCCCTGCTCATTGCTATG-3′) were used according to the protocol 
optimized by the World Health Organization H5 Reference Laboratory Network (7). Positive (219 bp) and nonspeciﬁ  c products from the 
PCR reaction are highlighted by the arrow and arrowhead, respectively. B) Detection of H5 virus in postmortem lung tissues from a patient 
with inﬂ  uenza (H5). Signals from the tested samples, positive control, and water control are indicated. C) Direct detection of inﬂ  uenza 
(H5) viruses from culture supernatants. Heat-treated supernatant from cells infected with A/Vietnam/1203/2004 were serially diluted and 
directly used as input in the LAMP assay. The plaque-forming units (pfu) of inﬂ  uenza (H5) virus in these reactions are shown.  LAMP for Inﬂ  uenza A (H5N1)
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and in online Appendix Figure 1, H5N1 subtype could still 
be detected by the assay. However, the detection limit (9.6 
pfu/reaction) was ≈1,000× less sensitive than the limit with 
puriﬁ  ed RNA as an input.
Conclusions
The RT-LAMP assay is highly speciﬁ  c, and its sensi-
tivity is comparable to that of an optimized RT-PCR assay 
for inﬂ  uenza (H5N1) viruses. The detection limit is equiva-
lent to that of a similar LAMP assay (12), but our assay was 
extensively tested by using a wide variety of inﬂ  uenza (H5) 
viruses, including recent clade 2 inﬂ  uenza (H5) viruses (9). 
LAMP does not require thermocyclers and gel electropho-
resis. Reactions can simply be incubated in a water bath or 
heating block, and the results can be conﬁ  rmed by direct 
visual inspection. Because early identiﬁ  cation of inﬂ  uenza 
(H5) is crucial for the containment of the disease, this novel 
assay can provide an efﬁ  cient option for the preliminary 
molecular detection of highly pathogenic inﬂ  uenza (H5) 
viruses in basic laboratory or clinical settings. Combined 
with the use of a turbidity meter, which costs much less 
than a real-time RT-PCR system, RT-LAMP can provide 
quantitative data for viral load studies. In conclusion, the 
LAMP assay is a promising tool for the detection of inﬂ  u-
enza (H5) viruses.
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Table. RT-LAMP assay results for highly pathogenic  
influenza A (H5N1)* 
Virus subtype Strain Result
H1 A/HK/54/98 –
H2 A/Singapore/57 –
H3 A/HK/1174/99 –
H4 A/duck/HK/MPA892/06 –
H5N1 A/HK/483/97 +
H5N1 A/HK/486/97 +
H5N1 A/chicken/HK/61.9/2002 +
H5N1 A/goose/HK/739.2/2002 +
H5N1 A/HK/213/03 +
H5N1 A/HK/212/03 +
H5N1 A/Thailand/MK2/04 +
H5N1 A/Vietnam/1203/04 +
H5N1 A/chicken/Indoneasia/4/2004 +
H5N1 A/chicken/Thailand/1/2004 +
H5N1 A/chicken/Vietnam/33/2004 +
H5N1 A/chicken/Wajo/BBVM/2005 +
H5N1 A/duck/Vietnam/568/2005 +
H5N1 A/bar-headed goose/Qinghai/5/2005  +
H6 A/teal/HK/W312/97 –
H7 A/env/HK/MPB127/05 –
H8 A/duck/HK/MP4275/2005 –
H9 A/duck/HK/G1/97 –
H10 A/env/HK/MPB839/05 –
H11 A/env/HK/MPB1679/06 –
H12 A/red necked stint/WA/5745/1984  –
H13 A/gull/Maryland/704/1977 –
H14 A/mallard/Gurjev/244/1982 –
H15 A/shelduck/WA/1762/1979 –
H16 A/gull/Denmark/68110/2002 –
*RT-LAMP, reverse transcription loop-mediated isothermal amplification; –, 
negative; +, positive. 